Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Reduction in serum IL-1β, IL-6, and IL-18 levels and Beck Depression Inventory-II score by combined sertraline and ketoprofen administration in major depressive disorder: A clinical trial, Neurology Psychiatry and Brain Research, December 2018, Elsevier,
DOI: 10.1016/j.npbr.2018.10.001.
You can read the full text:
Contributors
The following have contributed to this page
